Prosecution Insights
Last updated: October 25, 2026

Atomic Energy Of Canada Limited

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Atomic Energy Of Canada Limited maintains 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This workload is distributed across 1 distinct examiner and 1 distinct art unit. Such a focused presence in the biotechnology sector suggests a specialized application of the company's technology within this 1 distinct art unit. The limited scope of this art unit indicates that the company's current filings are not spread across diverse scientific disciplines.

The busiest examiner identified in the data is KELLY-O'NEILL, YOLANDA LYNNETTE, who is currently handling 1 pending office action. This individual workload matches the total workload for the entire portfolio. Consequently, the prosecution strategy is currently dependent on the interactions with this 1 distinct examiner. The presence of only 1 distinct examiner implies that all current legal correspondence is centralized through a particular channel at the patent office. This concentration allows for a specific focus on the requirements of KELLY-O'NEILL, YOLANDA LYNNETTE.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KELLY-O'NEILL, YOLANDA LYNNETTE 1 31.8% +23.7%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18560634 PROCESS FOR PRODUCING SYNTHETIC HYDROCARBONS FROM BIOMASS KELLY-O'NEILL, YOLANDA LYNNETTE —

Top Art Units

Art UnitApps
1692 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18560634 PROCESS FOR PRODUCING SYNTHETIC HYDROCARBONS FROM BIOMASS KELLY-O'NEILL, YOLANDA LYNNETTE 1692 §103 Non-Final OA — Pending Nov 13, 2023

Managing Atomic Energy Of Canada Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Atomic Energy Of Canada Limited have?

Atomic Energy Of Canada Limited has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Atomic Energy Of Canada Limited applications?

Yolanda Lynnette Kelly-O'Neill has the most, with 1 of Atomic Energy Of Canada Limited's pending office actions.

What technology area are Atomic Energy Of Canada Limited's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month